Translational and Regenerative Medicine

Novel Study Discovers ‘Metabolic Fingerprint’ to Help Treat, Diagnose and Prevent Cervical Cancer

PHOENIX – Researchers at the University of Arizona have completed the first-of-its-kind study that could aid in the treatment, diagnosis and prevention of cervical cancer by identifying cervicovaginal metabolic signatures, or “fingerprints,” that distinguish patients with HPV, pre-cancerous cervical conditions and cancer.

University of Arizona Cancer Center Seminar with Dr. Helen Ross

University of Arizona Cancer Center Seminar

Title: “Developing Trials in Locally Advanced Lung Cancer: The Role of Checkpoint Inhibition”

Helen J. Ross, MD
Candidate for Section Chief, Thoracic Oncology, UACC Phoenix

Associate Professor of Medicine
Mayo Clinic College of Medicine and Science      
Scottsdale, Arizona

Wednesday, May 15, 2019
12:00 – 1:00pm
UACC Tucson, Room 2920

Pages

Subscribe to RSS - Translational and Regenerative Medicine